Approval · Notice of Compliance 10170 · 2009
CANCIDAS: Notice of Compliance 10170
Issued April 22, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10170
- Date
- April 22, 2009
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New Indication: Children 17 years & younger
- Therapeutic class
- Antifungal
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CANCIDAS | Not yet assigned | — |
Medicinal ingredients
- CASPOFUNGIN ACETATE 50 MG per VIAL
- CASPOFUNGIN ACETATE 70 MG per VIAL